News & Analysis on Clinical Trial Services & Contract Research And Development
Kyowa Hakko Europe is to increase prices across its range of L-amino acids by ten per cent as of April 1, in an effort to stave off margin deterioration and ensure long-term availability of the ingredients.
Active pharmaceutical ingredient (API) specialist ScinoPharm has been assigned a drug master file (DMF) number for its anti-cancer ingredient docetaxel, the first such designation for the API in the US.
Indian biotech firm Biocon is planning to boost its contract research business as global pharma companies are increasingly looking to outsource R&D to India, according to media reports.
A Brazilian firm has signed a licensing deal to take advantage of a biopharmaceutical manufacturing technology which will allow the company to locally manufacture complex biopharmaceuticals destined for the South American market.
UK drug delivery and orthopaedic devices company The Medical House (TMH) is entering the second phase of a development project for a European defence agency involving its AutoSafety Injector (ASI) disposable autoinjector technology for the...